Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies

Retina

Volumn 30, Issue 3, 2010, Pages 509-515

  Soheilian, Masoud ^a,b   Karimi, Saeed ^a   Ramezani, Alireza ^a,b   Peyman, Gholam A ^c,d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Negah Eye Hospital   (Iran)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Intravitreal injection; Macular edema; NSAID

Indexed keywords

DICLOFENAC;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; ELECTRORETINOGRAPHY; EYE TOXICITY; FEMALE; HUMAN; MALE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; SINGLE DRUG DOSE; THICKNESS; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RETINA; VISUAL ACUITY; VITREOUS BODY;

EID: 77949349000     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181bdfa43     Document Type: Article

References (27)

1. Goa KL, Chrisp P. Ocular diclofenac. A review of its pharmacology and clinical use in cataract surgery, and potential in other inflammatory ocular conditions. Drugs Aging 1992;2: 473-486.
2. Snyder RW, Siekert RW, Schwiegerling J, Donnenfeld E, Thompson P. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. J Cataract Refract Surg 2000;26:1225-1227.
3. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J 2002;16:438-440.
4. Wilkinson-Berka JL. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cyclooxygenase-2 and nitric oxide. Curr Pharm Des 2004;10:3331-3348.
5. Weinreb RN, Polansky JR, Alvardo JA, Mitchell MD. Arachidonic acid metabolism in human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1988;29:1708-1712.
6. Preudhomme Y, Demolle D, Boeynaems JM. Metabolism of arachidonic acid in rabbit iris and retina. Invest Ophthalmol Vis Sci 1985;26:1336-1342.
7. Cheng T, Cao W, Wen R, Steinberg RH, LaVail MM. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest Ophthalmol Vis Sci 1998;39:581-591.
8. Alam CA, Seed MP, Willoughby DA. Angiostasis and vascular regression in chronic granulomatous inflammation induced by diclofenac in combination with hyaluronan in mice. J Pharm Pharmacol 1995;47:407-411.
9. Seed MP, Freemantle CN, Alam CA, et al. Apoptosis induction and inhibition of colon-26 tumor growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro and in vivo and topical diclofenac in hyaluronan. Adv Exp Med Biol 1997;433:339-342.
10. BenEzra D, Wysenbeek YS, Cohen E. Increased intraocular pressure during treatment for chronic uveitis. Graefes Arch Clin Exp Ophthalmol 1997;235:200-203.
11. Shen WY, Constable IJ, Chelva E, Rakoczy PE. Inhibition of diclofenac formulated in hyaluronan on angiogenesis in vitro and its intraocular tolerance in rabbit eye. Graefes Arch Clin Exp Ophthalmol 2000;238:273-282.
12. Schmid KE, Neumaier-Ammerer B, Stolba U, Binder S. Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c). Graefes Arch Clin Exp Ophthalmol 2006;244:1446-1452.
13. Bruns RF, Miller FD, Merriman RL, et al. Inhibition of protein kinase C by calphostin C is light-dependent. Biochem Biophys Res Commun 1991;176:288-293.
14. Patz A. Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol 1982;94:715-743.
15. Flynn JT. In: Eichenbaum JW, Mamelok AE, Mittl RN, Orellana J, eds. Treatment of Retinopathy of Prematurity. Chicago, IL: Year Book Medical Publishers; 1990:81-117.
16. Pe'er J, Shweiki D, Itin A, et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 1995;72:638-645.
17. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995;15:4738-4747.
18. Naveh N, Belkin M, Ben-Chaim O, Weissman C, Treister G. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment. Ophthalmic Res 1990;22:3-11.
19. Naveh N, Peer J, Bartov E, Weissman C. Argon laser irradiation of rabbits eyes-changes in prostaglandin E2 levels. Prostaglandins 1991;41:143-155.
20. Stjernschantz J. Autocoids and peptides in pharmacology of the eye. In: Sears ML, ed. Handbook of Experimental Pharmacology, Vol.69. Berlin: Springer-Verlag; 1984:311-365.
21. Audren F, Erginay A, Haouchine B, et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta Ophthalmol Scand 2006;84:624-630.
22. Kim SJ, Adams NA, Toma HS, et al. Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study. Retina 2008;28:595-605.
23. Starita C, Patel M, Katz B, Adamis AP. Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy. Dev Ophthalmol 2007;39: 122-148.
24. Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 2005;112:139-143.
25. Kothari HV, Lee WH, Ku EC. An alternate mechanism for regulation of leukotriene production in leukocytes: studies with an anti-inflammatory drug, sodium diclofenac. Biochem Biophys Acta 1987;921:502-511.
26. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol 1991;109:244-251.
27. Costagliola C, Parmeggiani F, Antinozzi PP, Caccavale A, Cotticelli L, Sebastiani A. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. Exp Eye Res 2005;81:610-615.